Search clinical trials for: Cytarabine (Cladribine Low Dose Cytarabine Backbone)
Total 174 results
-
Medical College of WisconsinNot yet recruitingRelapsed Adult AML | Refractory AMLUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruitingAcute Myeloid Leukemia, AdultChina
-
The First Affiliated Hospital of Soochow UniversityThe Second People's Hospital of Huai'an; First Affiliated Hospital Bengbu Medical... and other collaboratorsRecruiting
-
Jianxiang WangUnknownAcute Myeloid LeukemiaChina
-
Polish Adult Leukemia GroupRecruiting
-
CelgeneCompletedLeukemia, Myeloid | Isocitrate DehydrogenaseUnited States, Canada, China, Czechia, France, Germany, Italy, United Kingdom, Australia, Austria, Brazil, Denmark, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, Belgium
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia | Myeloid NeoplasmUnited States
-
Medical College of WisconsinRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
University of RochesterCompleted
-
Sun Yat-sen UniversityNot yet recruitingEfficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AMLAcute Myeloid Leukemia | Elderly Patients | Newly DiagnosedChina
-
Rigshospitalet, DenmarkRecruitingChildhood Cancer | Supportive CareDenmark
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
CephalonTerminatedAcute Myeloid LeukemiaUnited States, Canada
-
University of CincinnatiNovartisWithdrawnA Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid LeukemiaAcute Myeloid Leukemia | Chronic Myeloid Leukemia, Blast CrisisUnited States
-
Foghorn Therapeutics Inc.RecruitingRefractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Relapsed Acute Myeloid Leukemia | Relapsed Myelodysplastic Syndromes | Refractory Myelodysplastic Syndromes | Advanced Hematologic Malignancy | Relapsed Chronic Myelomonocytic LeukemiaUnited States
-
Sun Yat-sen UniversityUnknownCladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic LeukemiaAcute Lymphoblastic LeukemiaChina
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruitingBurkitt Lymphoma | Acute Lymphoblastic Leukemia, Adult | Lymphoblastic Lymphoma, AdultChina
-
University of Maryland, BaltimoreHematologics, IncRecruitingAcute Myeloid Leukemia Recurrent | Acute Myeloid Leukemia, Adult | Acute Myeloid Leukemia, Relapsed, AdultUnited States
-
Sunshine Lake Pharma Co., Ltd.Recruiting
-
Race Oncology LtdAstex Pharmaceuticals, Inc.WithdrawnAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeAustralia
-
Cornerstone PharmaceuticalsTerminatedRelapsed/Refractory Acute Myeloid LeukemiaUnited States, Spain, Korea, Republic of, France, Australia, Belgium, Austria, Germany, Poland
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States
-
Seagen Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Peking University Third HospitalNot yet recruitingPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
-
New York Medical CollegeUnknownAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Chronic Myelogenous Leukemia | Burkitts Leukemia/LymphomaUnited States
-
Institute of Hematology & Blood Diseases Hospital...Recruiting
-
Wake Forest University Health SciencesTerminated
-
wang, jianxiangRecruitingAcute Myeloid Leukemia | CEBPA Double MutationChina
-
University of FloridaGateway for Cancer Research; Cellworks Group Inc.WithdrawniCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic SyndromesMyelodysplastic SyndromesUnited States
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationChina, Malaysia, Russian Federation, Singapore, Thailand
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
University Hospital Inselspital, BerneWithdrawn
-
Asan Medical CenterUnknownAcute Myeloid LeukemiaKorea, Republic of
-
University Hospital Carl Gustav CarusGerman Research FoundationTerminated
-
AstraZenecaCompletedAcute Myeloid LeukemiaUnited States, France
-
PfizerUCB PharmaCompletedAcute Lymphoblastic LeukemiaUnited States, Canada, France, Spain, China, United Kingdom, Australia, Taiwan, Singapore, Korea, Republic of, Japan, Germany, Czechia, Poland, Italy, Netherlands, Argentina, Finland, Hungary, Sweden
-
French Innovative Leukemia OrganisationCompleted
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
M.D. Anderson Cancer CenterRecruiting
-
Incyte CorporationTerminated
-
CephalonCompletedAcute Myeloid LeukemiaUnited States, Canada, Australia, Germany, Israel, Italy, New Zealand, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine
-
Seoul National University HospitalCompletedChest PainKorea, Republic of
-
Hospital Israelita Albert EinsteinCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloproliferative Neoplasms | Myeloproliferative/Myelodysplastic NeoplasmBrazil
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Sun Yat-sen UniversityUnknownAcute Myeloid Leukemia | Relapse LeukemiaChina
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, B CellSwitzerland
-
Federal Research Institute of Pediatric Hematology...RecruitingLangerhans Cell HistiocytosisRussian Federation
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedMantle Cell Lymphoma | UntreatedUnited States
-
University of FloridaNot yet recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingSecondary Acute Myeloid LeukemiaUnited States